{"version":"1.0","type":"link","title":"From Gefitinib to Amivantamab: Progress and Perspectives of Therapies Targeting the Epidermal Growth Factor Receptor in the Era of Precision Oncology.","author_name":"Liu Z 외","author_url":"https://prs-insight.online/author/Liu%20Z","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/98151","thumbnail_width":1200,"thumbnail_height":630}